Market Watch & Perspectives on Vaccines Manufacturing in APAC

by Carole Inglevert | August 30, 2023

Vaccin_BNRs_R2_1200 x 628 pxl_ill_M

Merck KGaA, Darmstadt, Germany
MilliporeSigma
recently commissioned Economist Intelligence Clearstate, a division of The Economist, to conduct a study on the future of vaccine manufacturing in the Asia Pacific region. Nearly forty industry executives from biopharmaceutical companies, contract development and manufacturing organizations, and research institutes across ten countries were interviewed on topics ranging from the pros and cons of different vaccine modalities to technology adoption and envisioning the facility of the future.

In this whitepaper, we share key findings from this research on the future of vaccine manufacturing in the Asia Pacific region.

Read online

[molongui_author_box]

Related Posts

Sorry, we couldn't find any posts. Please try a different search.

Scroll to Top